These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4154788)

  • 21. Immunochemical evidence for the participation of cytochrome b5 in the NADH synergism of the NADPH-dependent mono-oxidase system of hepatic microsomes.
    Mannering GJ; Kuwahara S; Omura T
    Biochem Biophys Res Commun; 1974 Mar; 57(2):476-81. PubMed ID: 4151403
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of storage on microsomal mixed function oxidase activity in mouse liver.
    Litterst CL; Mimnaugh EG; Reagan RL; Gram TE
    Biochem Pharmacol; 1974 Sep; 23(17):2391-4. PubMed ID: 4139954
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of mirex on the activities of various rat hepatic mixed-function oxidases.
    Mehendale HM; Chen PR; Fishbein L; Matthews HB
    Arch Environ Contam Toxicol; 1973 Oct; 1(3):245-54. PubMed ID: 4204629
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of enzyme inducers on substrate specificity of the cytochrome P-450's.
    Conney AH; Lu AY; Levin W; Somogyi A; West S; Jacobson M; Ryan D; Kuntzman R
    Drug Metab Dispos; 1973; 1(1):199-210. PubMed ID: 4129867
    [No Abstract]   [Full Text] [Related]  

  • 25. Dietary fatty acid-induced alterations of hepatic microsomal drug metabolism.
    Norred WP; Wade AE
    Biochem Pharmacol; 1972 Nov; 21(21):2887-97. PubMed ID: 4646808
    [No Abstract]   [Full Text] [Related]  

  • 26. The influence of cytochrome P-450 induction on the metabolic formation of 455-NM complexes from amphetamines.
    Franklin MR
    Drug Metab Dispos; 1974; 2(3):321-6. PubMed ID: 4153124
    [No Abstract]   [Full Text] [Related]  

  • 27. Investigation of the effects of methyltestosterone, cortisone and spironolactone on the hepatic microsomal mixed function oxidase system in male and female rats.
    Hamrick ME; Zampaglione NG; Stripp B; Gillette JR
    Biochem Pharmacol; 1973 Feb; 22(3):293-310. PubMed ID: 4405689
    [No Abstract]   [Full Text] [Related]  

  • 28. Diphenylhydantoin effect on neonatal and adult rat hepatic drug metabolism.
    Eling TE; Harbison RD; Becker BA; Fouts JR
    J Pharmacol Exp Ther; 1970 Jan; 171(1):127-34. PubMed ID: 5410930
    [No Abstract]   [Full Text] [Related]  

  • 29. Biochemical effects of 3,5-diethoxycarbonyl-1,4-dihydrocollidine in mouse liver.
    Gayathri AK; Padmanaban G
    Biochem Pharmacol; 1974 Oct; 23(19):2713-25. PubMed ID: 4153782
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of chronic exposure to carbon disulphide upon some components of the electron transport system in rat liver microsomes.
    Sokal JA
    Biochem Pharmacol; 1973 Jan; 22(1):129-32. PubMed ID: 4148685
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on the effects of methylmercury on ethylmorphine N-demethylase and aniline hydroxylase activities and on the conversion of cytochrome P-450 to cytochrome P-420.
    Alvares AP; Cohn J; Kappas A
    Drug Metab Dispos; 1974; 2(3):259-66. PubMed ID: 4153087
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of reserpine pretreatment on microsomal enzyme activity.
    Stitzel RE
    Biochem Pharmacol; 1974 Sep; 23(17):2461-4. PubMed ID: 4429579
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug metabolism and drug-induced spectral interactions in human fetal liver microsomes.
    Pelkonen O
    Biochem Pharmacol; 1973 Oct; 22(19):2357-64. PubMed ID: 4147669
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of thiamin antagonists on drug hydroxylation and properties of cytochrome P-450 in the rat.
    Wade AE; Wu BC; Holbrook CM; Caster WO
    Biochem Pharmacol; 1973 Jul; 22(13):1573-80. PubMed ID: 4729804
    [No Abstract]   [Full Text] [Related]  

  • 35. Alteration of enzyme activity in rat liver following the acute and chronic administration of nicotine.
    Ruddon RW; Cohen AM
    Toxicol Appl Pharmacol; 1970 May; 16(3):613-25. PubMed ID: 4393061
    [No Abstract]   [Full Text] [Related]  

  • 36. Differential effects of benzodioxane, chroman, and dihydrobenzofuran analogs of clofibrate on various parameters of hepatic drug metabolism.
    Lewis NJ; Feller DR; Poochikian GK; Witiak DT
    J Med Chem; 1974 Jan; 17(1):41-5. PubMed ID: 4808468
    [No Abstract]   [Full Text] [Related]  

  • 37. Mechanisms of acute hepatic toxicity: chloroform, halothane, and glutathione.
    Brown BR; Sipes IG; Sagalyn AM
    Anesthesiology; 1974 Dec; 41(6):554-61. PubMed ID: 4433055
    [No Abstract]   [Full Text] [Related]  

  • 38. Proceedings: Comparison of the inducing effect of halothane and ethrane in rat liver.
    Rietbrock I; Richter E
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R79. PubMed ID: 4152370
    [No Abstract]   [Full Text] [Related]  

  • 39. Submicrosomal distribution of hepatic drug-metabolizing components in the Gunn rat.
    Guarino AM; Reagan RL; Gram TE
    Pharmacology; 1973; 10(5):257-71. PubMed ID: 4148758
    [No Abstract]   [Full Text] [Related]  

  • 40. Development of hepatic microsomal drug-oxidizing enzymes in immature male and female rats.
    MacLeod SM; Renton KW; Eade NR
    J Pharmacol Exp Ther; 1972 Dec; 183(3):489-98. PubMed ID: 4344247
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.